GovBidAlerts
← All opportunities

Japanese Encephalitis Vaccine (JEV)

Key dates

Posted
May 12, 2026
Response deadline
May 29, 2026, 3:59 AM UTC
Archive date
Archive type
auto15

Classification

Notice type
Presolicitation
Base type
Sources Sought
Set-aside
No Set aside used
Set-aside code
NONE
PSC
6505

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
097.97AS.DLA TRP SUPT MED.SPE2DP
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
Street 2
City
Philadelphia
State
Pennsylvania
Zip
19111
Country
UNITED STATES

Contacts

Description

Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis Solicitation: SPE2DP-26-R-0001 Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) NSN: 6505-01-607-7018 Description: The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice. The Solicitation will be issued under authority 10 U.S.C. § 3204(a)(1), implemented by FAR 6.302-1 (“Only one responsible source and no other supplies or services will satisfy agency requirements”). The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2). The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each. Inspection/Acceptance at Destination FOB Destination Delivery Destination: DODAAC: SV3100 DLA Distribution Susquehanna U Avenue, Bldg. 89, Door 6 New Cumberland, PA 17070 Attn: Jim Earp Production Lead Time is 120 days after issuance date of the delivery order (DD1155). All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have FDA approval to sell JEV prior to the Solicitation’s closing date and time. **************************************************************************** IMPORTANT NOTICES Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024. ****************************************************************************** Contracting Office Address: Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES Point of Contact(s): Alec Deichman, Contracting Specialist, Phone: 445-737-5743 , Email: Alec.Deichman@dla.mil Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil

Attachments (2)

Similar open contracts

Metadata

Notice ID
e0abb49f450b46948131badea274b87f
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
097.97AS.DLA TRP SUPT MED.SPE2DP
Ingested
May 13, 2026
Updated
Jun 12, 2026